Cargando…

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

BACKGROUND: Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a common cause of disease acceleration in IPF and has a major impact on mortality. The role of macrophage activation in AE of IPF has never been addressed before. METHODS: We evaluated BAL cell cytokine profiles and BAL di...

Descripción completa

Detalles Bibliográficos
Autores principales: Schupp, Jonas Christian, Binder, Harald, Jäger, Benedikt, Cillis, Giuseppe, Zissel, Gernot, Müller-Quernheim, Joachim, Prasse, Antje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295887/
https://www.ncbi.nlm.nih.gov/pubmed/25590613
http://dx.doi.org/10.1371/journal.pone.0116775
_version_ 1782352895682805760
author Schupp, Jonas Christian
Binder, Harald
Jäger, Benedikt
Cillis, Giuseppe
Zissel, Gernot
Müller-Quernheim, Joachim
Prasse, Antje
author_facet Schupp, Jonas Christian
Binder, Harald
Jäger, Benedikt
Cillis, Giuseppe
Zissel, Gernot
Müller-Quernheim, Joachim
Prasse, Antje
author_sort Schupp, Jonas Christian
collection PubMed
description BACKGROUND: Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a common cause of disease acceleration in IPF and has a major impact on mortality. The role of macrophage activation in AE of IPF has never been addressed before. METHODS: We evaluated BAL cell cytokine profiles and BAL differential cell counts in 71 IPF patients w/wo AE and in 20 healthy volunteers. Twelve patients suffered from AE at initial diagnosis while sixteen patients developed AE in the 24 months of follow-up. The levels of IL-1ra, CCL2, CCL17, CCL18, CCL22, TNF-α, IL-1β, CXCL1 and IL-8 spontaneously produced by BAL-cells were analysed by ELISA. RESULTS: In patients with AE, the percentage of BAL neutrophils was significantly increased compared to stable patients. We found an increase in the production rate of the pro-inflammatory cytokines CXCL1 and IL-8 combined with an increase in all tested M2 cytokines by BAL-cells. An increase in CCL18 levels and neutrophil counts during AE was observed in BAL cells from patients from whom serial lavages were obtained. Furthermore, high baseline levels of CCL18 production by BAL cells were significantly predictive for the development of future AE. CONCLUSIONS: BAL cell cytokine production levels at acute exacerbation show up-regulation of pro-inflammatory as well as anti-inflammatory/ M2 cytokines. Our data suggest that AE in IPF is not an incidental event but rather driven by cellular mechanisms including M2 macrophage activation.
format Online
Article
Text
id pubmed-4295887
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42958872015-01-22 Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis Schupp, Jonas Christian Binder, Harald Jäger, Benedikt Cillis, Giuseppe Zissel, Gernot Müller-Quernheim, Joachim Prasse, Antje PLoS One Research Article BACKGROUND: Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a common cause of disease acceleration in IPF and has a major impact on mortality. The role of macrophage activation in AE of IPF has never been addressed before. METHODS: We evaluated BAL cell cytokine profiles and BAL differential cell counts in 71 IPF patients w/wo AE and in 20 healthy volunteers. Twelve patients suffered from AE at initial diagnosis while sixteen patients developed AE in the 24 months of follow-up. The levels of IL-1ra, CCL2, CCL17, CCL18, CCL22, TNF-α, IL-1β, CXCL1 and IL-8 spontaneously produced by BAL-cells were analysed by ELISA. RESULTS: In patients with AE, the percentage of BAL neutrophils was significantly increased compared to stable patients. We found an increase in the production rate of the pro-inflammatory cytokines CXCL1 and IL-8 combined with an increase in all tested M2 cytokines by BAL-cells. An increase in CCL18 levels and neutrophil counts during AE was observed in BAL cells from patients from whom serial lavages were obtained. Furthermore, high baseline levels of CCL18 production by BAL cells were significantly predictive for the development of future AE. CONCLUSIONS: BAL cell cytokine production levels at acute exacerbation show up-regulation of pro-inflammatory as well as anti-inflammatory/ M2 cytokines. Our data suggest that AE in IPF is not an incidental event but rather driven by cellular mechanisms including M2 macrophage activation. Public Library of Science 2015-01-15 /pmc/articles/PMC4295887/ /pubmed/25590613 http://dx.doi.org/10.1371/journal.pone.0116775 Text en © 2015 Schupp et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Schupp, Jonas Christian
Binder, Harald
Jäger, Benedikt
Cillis, Giuseppe
Zissel, Gernot
Müller-Quernheim, Joachim
Prasse, Antje
Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title_full Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title_fullStr Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title_full_unstemmed Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title_short Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title_sort macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295887/
https://www.ncbi.nlm.nih.gov/pubmed/25590613
http://dx.doi.org/10.1371/journal.pone.0116775
work_keys_str_mv AT schuppjonaschristian macrophageactivationinacuteexacerbationofidiopathicpulmonaryfibrosis
AT binderharald macrophageactivationinacuteexacerbationofidiopathicpulmonaryfibrosis
AT jagerbenedikt macrophageactivationinacuteexacerbationofidiopathicpulmonaryfibrosis
AT cillisgiuseppe macrophageactivationinacuteexacerbationofidiopathicpulmonaryfibrosis
AT zisselgernot macrophageactivationinacuteexacerbationofidiopathicpulmonaryfibrosis
AT mullerquernheimjoachim macrophageactivationinacuteexacerbationofidiopathicpulmonaryfibrosis
AT prasseantje macrophageactivationinacuteexacerbationofidiopathicpulmonaryfibrosis